Recommended Pages at rttnews.com
Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding
rttnews.com — “Drugmaker Merck & Co. (MRK) Saturday said its experimental blood thinner vorapaxar in combination with standard of care was seen to significantly reduce cardio vascular events in heart patients, but saw an increase in bleeding especially in those who have had a stroke.” View full resource at rttnews.com
Most Recently Shared on March 25, 2012 at 5:05 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding - RTT News http://t.co/yedpZo95 #health
Threshold Pharma's TH-302 Receives EC's Orphan Drug Designation
rttnews.com — “Threshold Pharmaceuticals, Inc. (THLD) Friday said the European Commission has granted Orphan Drug Designation for TH-302, a hypoxia-targeted drug, for the treatment of soft tissue sarcoma.” View full resource at rttnews.com
Most Recently Shared on March 16, 2012 at 12:22 pm By:
Threshold Pharma grabs European orphan nod for phase III sarcoma drug http://t.co/IvyWWOGT #cancer $THLD
Say No To Cigarettes; Tune In On March 19 To Know Why
rttnews.com — “Seeking to encourage smokers to quit and deter children from ever beginning to smoke, the Centers for Disease Control and Prevention has launched a national ad campaign named "Tips from Former Smokers".” View full resource at rttnews.com
Most Recently Shared on March 16, 2012 at 11:11 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Why Say No To Cigarettes? - Tune In On March 19 - RTT News http://t.co/4I8AR749 #health
Red Meat Can Send Us To An Early Grave, Study Says
rttnews.com — “Eating unprocessed and processed red meat regularly may shorten one's life span, according to researchers from Harvard School of Medicine. Replacement of red meat with alternative healthy dietary components, such as fish, poultry, nuts, legumes, low-fat dairy products, and whole grains may lower the mortality risk.” View full resource at rttnews.com
Most Recently Shared on March 13, 2012 at 2:48 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Red Meat Can Send Us To An Early Grave, Study Says - RTT News http://t.co/UE8SsnFm #health
Bone Drug Could Help Battle Breast Cancer
rttnews.com — “A drug used to protect the bones of patients receiving treatment for breast cancer could help raise survival rates of women with breast cancer. Researchers studied over 1,800 pre-menopausal women receiving the bone-strengthening drug Zometa with their breast cancer treatment over seven years.” View full resource at rttnews.com
Most Recently Shared on December 15, 2011 at 10:34 pm By:
Men For A Cause (TM) Health Organization
Bone Drug Could Help Battle #BreastCancer http://t.co/uDKiIuBc
Santarus Inc - A Look Ahead
rttnews.com — “Ulcerative colitis, which is an inflammatory bowel disease, is a chronic inflammation of the large intestine, accompanied by symptoms of abdominal pain and bloody diarrhea.” View full resource at rttnews.com
Most Recently Shared on November 16, 2011 at 1:27 pm By:
Santarus Inc - A Look Ahead: Ulcerative colitis, which is an inflammatory bowel disease, is a chronic inflammati... http://t.co/uM6ieeN6
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product
rttnews.com — “Baxter International Inc. (BAX) Thursday reported initiating the Phase III trial of its investigational recombinant von Willebrand factor, or rWWF, BAX 111 as preventive therapy for patients with von Willebrand disease, an inherited bleeding disorder.” View full resource at rttnews.com
Most Recently Shared on October 17, 2011 at 2:28 am By:
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product
rttnews.com — “Baxter International Inc. (BAX) Thursday reported initiating the Phase III trial of its investigational recombinant von Willebrand factor, or rWWF, BAX 111 as preventive therapy for patients with von Willebrand disease, an inherited bleeding disorder.” View full resource at rttnews.com
Most Recently Shared on October 17, 2011 at 2:28 am By:
Susan Scroggins - vWD Arkansas Patient Advocate and Active Health Library
Baxter Starts Phase III Trial Of Recombinant Von Willebrand Factor Product http://t.co/TA5NFFWP via @rttnews
Antares Pharma - On The Move
rttnews.com — “In a little more than two months' time, the U.S. Food and Drug Administration is all set to announce its decision on whether or not to approve Antares Pharma Inc.” View full resource at rttnews.com
Most Recently Shared on September 27, 2011 at 4:58 pm By:
Antares Pharma - On The Move: In a little more than two months' time, the U.S. Food and Drug Administration is a... http://t.co/UZnXsQ4S
New York Firm Recalls Meat Products Over Allergy Risk
rttnews.com — “M & P Food Production Ltd., a Brooklyn, New York-based manufacturer and distributor of frozen foods, is recalling about 11,000 lbs. of chicken, beef, veal, and pork dumpling products due to an undeclared milk allergen that is not noted on the label.” View full resource at rttnews.com
Most Recently Shared on September 21, 2011 at 11:53 am By:
New York Firm Recalls Meat Products Over Allergy Risk http://t.co/W7tUUa55
Allergy Therapeutics Posts Full Year Loss Of 2.66 Mln Pounds - Quick Facts
rttnews.com — “Allergy Therapeutics Plc (AGY.L) posted loss of 2.66 million pounds or 0.86 pence per share for the year to June 30, 2011 versus profit of 586 thousand pounds or 0.” View full resource at rttnews.com
Most Recently Shared on September 19, 2011 at 7:16 am By:
Allergy Therapeutics Posts Full Year Loss Of 2.66 Mln Pounds - Quick Facts http://t.co/IPndsvMi
Bayer, J&J Blood Thinner Gets FDA Panel Backing For New Indication
rttnews.com — “Blood thinner Xarelto, co-developed by Bayer HealthCare, a subsidiary of German chemical and pharmaceutical giant Bayer AG (BYR.L) (BAYRY.PK) and Johnson & Johnson (JNJ) won an FDA expert panel vote Thursday, backing the approval of the drug for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in the U.” View full resource at rttnews.com
Most Recently Shared on September 9, 2011 at 12:28 pm By:
Drugs and Devices OW OW Health
Bayer, J&J Stroke Drug Gets FDA Panel Backing - RTT News: USA TodayBayer, J&J Stroke Drug Gets FDA Panel B... http://t.co/ruIUBoN #drug
Actelion's Mid-stage Study Of IPF Drug Macitentan Fails To Meet Primary Goal
rttnews.com — “Swiss biopharmaceutical company Actelion Ltd (ALIOF.PK) on Monday said an exploratory phase II study with macitentan in patients with idiopathic pulmonary fibrosis or IPF did not meet its primary endpoint of forced vital capacity.” View full resource at rttnews.com
Most Recently Shared on August 29, 2011 at 8:55 am By:
Drugs and Devices OW OW Health
Actelion's Mid-stage Study Of IPF Drug Macitentan Fails To Meet Primary Goal - RTT News: Actelion's Mid-st... http://t.co/20B5aeF #drug
Google Forfeits $500 Mln As Settlement With DoJ On Online Drug Ads
rttnews.com — “Internet search giant Google, Inc. (GOOG) reached Wednesday a $500 million settlement with the Justice department related to placing of advertisement from online Canadian pharmacies through its AdWords program.” View full resource at rttnews.com
Most Recently Shared on August 25, 2011 at 3:25 am By:
Drugs and Devices OW OW Health
Google Forfeits $500 Mln As Settlement With DoJ On Online Drug Ads - RTT News: Telegraph.co.ukGoogle Forfe... http://t.co/vlYvpiA #drug
Serco H1 Profit Rises - Update
rttnews.com — “UK-based outsourcing and support services provider Serco Group Plc (SRP.L) Wednesday reported a higher first-half profit, driven by its international portfolio. For the full year 2011, the company still expects good organic revenue growth and further progress on operating margin.” View full resource at rttnews.com
Most Recently Shared on August 24, 2011 at 1:41 pm By:
Serco H1 Profit Rises - Update http://t.co/yntY31y
